About Us.

Inspiring and accelerating action to end the epidemic.

The Foundation for Opioid Response Efforts (FORE) was founded in 2018 as a private, national, grantmaking foundation focused solely on addressing the opioid epidemic.

We are committed to convening and supporting partners advancing patient-centered, innovative, evidence-based solutions addressing this crisis.

With patients at the center, we are focused on supporting programs and grants in four key areas:
Provider education Provider education
Payer strategies Payer strategies
Policy initiatives Policy initiatives
Public awareness Public awareness

Collaboration is key to ending the opioid epidemic. Now more than ever, it is critical for us to think creatively, test new approaches, remove silos, and enhance and expand activities proven to prevent and reduce opioid use disorder.

We welcome the opportunity to explore partnerships and collaborate with all who are dedicated to furthering our goal of accelerating solutions to end this crisis.

A Letter from
our President:
Karen A. Scott - President

FORE is a new national grantmaking organization focused solely on ending the nation’s opioid epidemic. We are deeply committed to enhancing access to care for Americans struggling with opioid use disorder and enabling communities to invest in prevention.

The cost of inaction is simply too high. Over 130 Americans die every day from opioid overdoses. Families are suffering while the resources of clinicians, first responders, and others are stretched thin. The stigma of addiction and shortage of evidence-based prevention and treatment options have left many without the help they need.

Our funding priorities are being shaped by convening leaders in addiction medicine, pain management, public health, health policy, and health care delivery. I am grateful to those who have given their time to inform our efforts to help everyone affected by this devastating crisis.

No single solution will solve this epidemic. For this reason, we will be supporting patient-centered efforts that aim to achieve the following:

  • Educate healthcare providers about prevention and evidence-based treatment
  • Develop sustainable prevention, treatment, and recovery models and payment approaches
  • Inform State and Federal policies to ensure access to care
  • Raise public awareness of effective strategies for curtailing the epidemic

We look forward to developing a strong network of grantees, partners, and collaborators.

Karen A. Scott

President signature
FORE Leadership & Staff

Our leadership and staff are renowned experts with the vision and passion to drive our mission forward.

Andrea Barthwell, M.D., DFASAM, Board Chair Medical Director at Encounter Medical Group; Founder and CEO of Two Dreams Chicago

Dr. Barthwell, past president of the American Society of Addition Medicine (ASAM), is Founder of Encounter Medical Group, P.C., and Director at Two Dreams, a comprehensive alcoholism and addiction treatment system. From 2003-2004, she served as Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP).

Adrienne M. Brown, MSW, LMSW

Ms. Brown is a dedicated social services professional with over 30 years of experience in providing high quality support services to diverse communities. She served as a senior administrator at Alcoholics Anonymous World Services for 17 years. Ms. Brown is a certified recovery peer advocate.

Lori A. Schechter, J.D. Executive Vice President, Chief Legal Officer & General Counsel at McKesson Corporation

Ms. Schechter is Executive Vice President, Chief Legal Officer & General Counsel for the McKesson Corporation. Previously, she was a litigation partner at Morrison & Foerster where she represented clients in complex litigation and investigations. She was named by the National Law Journal as one of the “Top 50 Female Litigators in the Country.” She currently serves on the Board of the National Center for Youth Law, and previously served on the Board of Legal Aid at Work.

Richard S. Schottenfeld, M.D. Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Howard University College of Medicine

Dr. Schottenfeld is a leading clinical researcher, educator, and developer of drug use clinical programs and services. He has authored more than 125 peer-reviewed publications and has played a key role in the development and expansion of primary care-based treatments for OUD. He is currently the PI of a NIDA-funded Clinical Trials Network study investigating innovative strategies for addressing stigma and expanding treatment and recovery services in urban, poor, and minority communities.

Peter Slone Senior Vice President of Corporate Public Affairs at McKesson Corporation

Mr. Slone has been Senior Vice President of Corporate Public Affairs at the McKesson Corporation since June 2015. Previously, he was Vice President of Global Government Affairs at Medtronic plc, where he served for over 13 years.

Adam Usdan President of Trellus Management Corporation LLC

Mr. Usdan has been in the investment advisory industry for over 32 years, founding Trellus Partners in 1994. Mr. Usdan began his investment career in 1987 at Odyssey Partners, where he was responsible for managing long/short U.S. equity. He currently serves on the Boards of Griffin Mining, Wesleyan University, The Jewish Board for Children and Family Services, and The Jonas Center for Nursing and Veterans Healthcare.

FORE was started with an initial donation from the McKesson Corporation.